Your browser doesn't support javascript.
loading
Patient-Reported Outcomes With Belantamab Mafodotin Treatment in Patients With Triple-Class Refractory Multiple Myeloma.
Popat, Rakesh; Lonial, Sagar; Voorhees, Peter M; Esposti, Simona Degli; Gorsh, Boris; Gupta, Ira; Opalinska, Joanna; Sapra, Sandhya; Piontek, Trisha; He, Zangdong; Kleinman, David; Schaumberg, Debra; Regnault, Antoine; Meunier, Juliette; Eliason, Laurie.
Afiliación
  • Popat R; From NIHR University College London Hospitals Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, UK.
  • Lonial S; Emory University, Winship Cancer Institute, Atlanta, Georgia, USA.
  • Voorhees PM; Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
  • Esposti SD; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
  • Gorsh B; GSK, Upper Providence, Pennsylvania, USA.
  • Gupta I; GSK, Upper Providence, Pennsylvania, USA.
  • Opalinska J; GSK, Upper Providence, Pennsylvania, USA.
  • Sapra S; GSK, Upper Providence, Pennsylvania, USA.
  • Piontek T; GSK, Upper Providence, Pennsylvania, USA.
  • He Z; GSK, Upper Providence, Pennsylvania, USA.
  • Kleinman D; Flaum Eye Institute, University of Rochester, Rochester, New York, USA.
  • Schaumberg D; University of Utah School of Medicine, Department of Ophthalmology & Visual Sciences, Salt Lake City, Utah, USA.
  • Regnault A; Modus Outcomes, Lyon, France.
  • Meunier J; Modus Outcomes, Lyon, France.
  • Eliason L; GSK, Upper Providence, Pennsylvania, USA.
J Adv Pract Oncol ; 14(6): 503-518, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37808071

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: J Adv Pract Oncol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: J Adv Pract Oncol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido